Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Insider

HYPD

Hyperion DeFi Inc

May 06 • 10:36AM ET

3.38

-1.29 -27.62 %

Healthcare • Biotechnology • USA • Nano • NASD

Today, 7:06 AMHyperion DeFi prices 2,777,778-share public offering at $3.60 for expected gross proceeds of about $10M, grants underwriters 30-day option for additional shares

Peers: ALDX OCUL EDIT KALA XERS NCNA PRPH CRVS PRQR OPTN

| Held by: VXF BTEC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-8.71	Insider Own	39.51%	Shs Outstand	8.68M	Perf Week	-14.65%
Market Cap	37.10M	Forward P/E	6.85	EPS next Y	0.49	Insider Trans	4.39%	Shs Float	6.89M	Perf Month	10.10%
Enterprise Value	39.17M	PEG	-	EPS next Q	1.32	Inst Own	21.85%	Short Float	16.30%	Perf Quarter	-7.40%
Income	-51.26M	P/S	45.80	EPS this Y	115.59%	Inst Trans	22.50%	Short Ratio	3.12	Perf Half Y	-42.91%
Sales	0.81M	P/B	0.71	EPS next Y	-66.33%	ROA	-163.50%	Short Interest	1.12M	Perf YTD	-5.06%
Book/sh	4.73	P/C	5.76	EPS next 5Y	-	ROE	-324.08%	52W High	17.18 -80.33%	Perf Year	228.16%
Cash/sh	0.59	P/FCF	-	EPS past 3/5Y	47.93% 34.01%	ROIC	-104.47%	52W Low	1.02 231.37%	Perf 3Y	-99.08%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -16.47%	Gross Margin	-472.54%	Volatility	10.31% 10.06%	Perf 5Y	-99.11%
Dividend TTM	-	EV/Sales	48.36	EPS Y/Y TTM	86.28%	Oper. Margin	-2333.42%	ATR (14)	0.47	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.68	Sales Y/Y TTM	1318.75%	Profit Margin	-6301.06%	RSI (14)	42.42	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.68	EPS Q/Q	73.31%	SMA20	-15.38%	Beta	2.57	Target Price	6.85
Payout	-	Debt/Eq	0.21	Sales Q/Q	1666.38%	SMA50	-6.23%	Rel Volume	18.76	Prev Close	4.67
Employees	9	LT Debt/Eq	0.19	Earnings	May 14 BMO	SMA200	-37.74%	Avg Volume	360.46K	Price	3.38
IPO	Jan 25, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	-300.64% -28.94%	Trades		Volume	1,425,166	Change	-27.62%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-24-25	Initiated	Chardan Capital Markets	Buy
Dec-16-25	Initiated	Cantor Fitzgerald	Overweight	$4
Nov-18-24	Downgrade	H.C. Wainwright	Buy → Neutral	$12 → $2
Mar-01-21	Initiated	Northland Capital	Outperform	$10
Feb-03-20	Downgrade	Oppenheimer	Outperform → Perform

Today 07:00AM	Hyperion DeFi Announces Pricing of Public Offering of Common Stock (GlobeNewswire) -27.62%
May-05-26 04:01PM	Hyperion DeFi Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
May-01-26 11:12AM	Hyperion DeFi Schedules First Quarter Earnings Call for Thursday, May 14 at 8:00 a.m. ET (GlobeNewswire)
Apr-27-26 10:50AM	Hyperion DeFi Announces Participation in Upcoming Investor and Industry Conferences (GlobeNewswire) +5.28%
Mar-26-26 03:00PM	Hyperion DeFi Inc (HYPD) Q4 2025 Earnings Call Highlights: Surging Revenue and Strategic ... (GuruFocus.com) -5.68%
07:00AM	Loading…
07:00AM	Hyperion DeFi Reports 4Q and FY 2025 Financial Results with Quarter-over-Quarter Growth of +64% Revenue and +87% Adjusted Gross Profit (GlobeNewswire)
Mar-24-26 08:00AM	Hyperion DeFi Enters HAUS Agreement with Silhouette (GlobeNewswire)
Mar-17-26 09:00AM	Hyperion DeFi Schedules Fourth Quarter and Full Year 2025 Earnings Call for Thursday, March 26 at 8:00 a.m. ET (GlobeNewswire)
Mar-09-26 08:00AM	Hyperion DeFi Announces Private Lending Pool Built by HyperLend (GlobeNewswire) +9.32%
Feb-23-26 04:25AM	Arthur Hayes' Crypto Portfolio Beyond Bitcoin, Ethereum: One Bet Has Crashes 55% YTD While Another Climbs 13% (Benzinga) -9.12%
Feb-05-26 01:25AM	Hyperliquid Treasury Eyes Yield by Using HYPE as Options Collateral (99bitcoins) -5.21%
Feb-04-26 08:00AM	Hyperion DeFi Announces Institutional Volatility Income Vault Built on Rysk Protocol (GlobeNewswire) -10.10%
Jan-28-26 09:31AM	Hyperliquid Roars Past XRP, BNB With 65% Rally: Why Treasury Companies Buy The HYPE (Benzinga) +7.67%
Jan-12-26 08:00AM	Hyperion DeFi Issues Letter to Shareholders (GlobeNewswire) +5.15%
Jan-05-26 08:00AM	Hyperion DeFi Appoints Hyunsu Jung as Chief Executive Officer (GlobeNewswire) +10.61%
09:36AM	Loading…
Dec-24-25 09:36AM	KB Home downgraded, Costco upgraded: Wall Street's top analyst calls (The Fly) +7.20%
09:36AM	KB Home downgrade, Costco upgraded: Wall Street's top analyst calls (The Fly)
Dec-04-25 08:00AM	Hyperion DeFi Announces Receipt of Kinetiq Airdrop, Partnership with Native Markets, and Purchase of 150,000 Additional HYPE (GlobeNewswire) +9.97%
Nov-14-25 12:05AM	Hyperion DeFi Inc (HYPD) Q3 2025 Earnings Call Highlights: Record Income and Strategic ... (GuruFocus.com)
Nov-13-25 04:05PM	Hyperion DeFi Reports Third Quarter 2025 Financial Results with Record Net Income of $6.6 Million (GlobeNewswire) -7.79%
Nov-03-25 04:00PM	Hyperion DeFi Schedules Third Quarter 2025 Earnings Call for November 13, 2025 (GlobeNewswire) -8.64% -8.53%
Oct-29-25 08:00AM	Hyperion DeFi Announces Strategic Partnership with Felix to Launch HIP-3 Powered Perpetual Futures Market (GlobeNewswire) -11.86%
Sep-29-25 10:17AM	Former PayPal Lead David Knox Moves to Hyperliquid-Dedicated Treasury Hyperion as it Scales HYPE Portfolio (CCN) +7.00%
08:00AM	Hyperion DeFi Announces Appointment of David Knox as Chief Financial Officer (GlobeNewswire)
Sep-27-25 07:30AM	Many crypto-treasury companies are trading for less than what their digital assets are worth. Is this a bargain or a big red flag? (MarketWatch)
Sep-25-25 08:00AM	Hyperion DeFi Adds $10M in HYPE to its Treasury Holdings (GlobeNewswire) -11.97%
Sep-16-25 08:00AM	Hyperion DeFi Enters Into First HAUS Agreement With Proprietary Trading Firm Credo (GlobeNewswire)
Sep-12-25 09:00AM	Corporate Treasury Revolution Accelerates as $113 Billion Bitcoin Holdings Spark 150% Stock Surges (PR Newswire) +24.94%
Sep-09-25 08:00AM	Hyperion DeFi Strengthens Leadership Team With Key Appointments to Accelerate DeFi Strategy (GlobeNewswire) +35.03%
Sep-05-25 10:55AM	Corporate Crypto Treasury Surge Accelerates as Bitcoin Hits Fresh Institutional Milestone (PR Newswire)
03:14AM	Loading…
Aug-14-25 03:14AM	Hyperion DeFi Inc (HYPD) Q2 2025 Earnings Call Highlights: Strategic Innovations and Financial ... (GuruFocus.com)
Aug-13-25 04:01PM	Hyperion DeFi Provides Corporate Update and Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-12-25 09:40AM	Hyperion DeFi Inc (HYPD) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com) -7.66%
Aug-08-25 04:05PM	Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025 (GlobeNewswire) +35.64%
Jul-28-25 08:00AM	Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy (GlobeNewswire) +23.38%
Jul-17-25 08:00AM	Hyperion DeFi to Host Corporate Update Event to Discuss Strategic Evolution from Eyenovia and the Future of On-Chain Finance on July 29, 2025 (GlobeNewswire)
Jul-14-25 04:05PM	Hyperion DeFi Adds $5 Million in HYPE to its Treasury Holdings (GlobeNewswire) -9.07% +7.11%
Jul-02-25 08:00AM	Eyenovia Announces Rebranding and Corporate Name Change to Hyperion DeFi, Inc. (GlobeNewswire) +49.81%
Jun-30-25 08:00AM	Eyenovia Adds $10 Million in HYPE to its Treasury Holdings in Preparation for Strategic Onchain Engagement (GlobeNewswire)
Jun-25-25 08:30AM	Eyenovia Announces Co-Branded Validator with Kinetiq (GlobeNewswire) +5.88%
Jun-23-25 08:30AM	Eyenovia Announces Closing of $50 Million Private Placement, Successful Accumulation of More Than One Million HYPE Tokens, and Update on its Optejet Development Program (GlobeNewswire) +30.17%
Jun-18-25 02:04PM	Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings (PR Newswire) -30.70%
08:32AM	Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group (GlobeNewswire)
Jun-17-25 02:55PM	Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy (GlobeNewswire) +134.68%
May-19-25 05:30PM	Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results (GlobeNewswire) +47.79%
Apr-10-25 07:00AM	Eyenovia Provides Development Update on Optejet User Filled Device (UFD) (GlobeNewswire)
Mar-20-25 03:11PM	Eyenovia Shares Drop 14% Amid Betaliq Merger Talks (GuruFocus.com) -13.77%
10:24AM	Eyenovia falls on plans to seek reverse merger (SeekingAlpha)
07:00AM	Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq (GlobeNewswire)
Feb-26-25 07:00AM	Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements (GlobeNewswire) +16.56%
Feb-24-25 07:00AM	Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives (GlobeNewswire) -5.36%
Feb-05-25 07:00AM	Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device (GlobeNewswire) -12.82%
Jan-28-25 04:05PM	Eyenovia Announces 1-for-80 Reverse Stock Split (GlobeNewswire) -34.74%
Jan-15-25 07:00AM	Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote FOR Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders (GlobeNewswire) -23.37%
Jan-06-25 07:00AM	Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives (GlobeNewswire) +9.17%
Dec-06-24 08:00AM	Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering (GlobeNewswire) -9.49%
Nov-25-24 08:00AM	Eyenovia, Inc. Announces Pricing of $1.3 Million Registered Direct Offering (GlobeNewswire) -17.38%
Nov-23-24 07:05AM	Eyenovia taking additional actions to reduce personnel-related costs by over 70% (TipRanks)
Nov-22-24 07:00AM	Eyenovia Provides Update on Restructuring Efforts (GlobeNewswire)
Nov-19-24 06:15AM	Eyenovia downgraded to Neutral from Buy at H.C. Wainwright (TipRanks) +7.39%
Nov-18-24 07:38AM	Eyenovia stock plummets following Phase III myopia trial failure (Clinical Trials Arena) +8.93%
Nov-15-24 01:15PM	Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline (Benzinga) -70.04%
07:00AM	Eyenovia Provides Update on Phase 3 CHAPERONE Study (GlobeNewswire)
Nov-13-24 02:17AM	Eyenovia Inc (EYEN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges (GuruFocus.com) -19.35%
Nov-12-24 05:45PM	Eyenovia, Inc. (EYEN) Reports Q3 Loss, Misses Revenue Estimates (Zacks) +8.85%
04:05PM	Eyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-07-24 07:00AM	Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th (GlobeNewswire)
Oct-23-24 07:00AM	Eyenovia Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered with the Optejet (GlobeNewswire)
Oct-16-24 07:00AM	Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo (GlobeNewswire) +22.17%
Oct-14-24 09:55AM	Here's Why Eyenovia (EYEN) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Oct-09-24 06:13PM	Eyenovia Inc (EYEN) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges (GuruFocus.com)
Oct-01-24 07:00AM	Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device (GlobeNewswire)
Sep-27-24 08:30AM	Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering (GlobeNewswire) +6.93%
Sep-26-24 07:00AM	Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery (GlobeNewswire)
Sep-09-24 06:53AM	Formosa Pharma ships APP13007 ophthalmic drug to US (Pharmaceutical Technology) +14.35%
03:00AM	Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization (PR Newswire)
Sep-05-24 07:00AM	Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S. (GlobeNewswire)
Sep-03-24 07:00AM	Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer (GlobeNewswire)
Aug-23-24 11:42AM	Eyenovia Announces Closing of Public Offering (GlobeNewswire) +6.53%
Aug-21-24 09:29AM	Eyenovia Announces Pricing of $5.14 Million Public Offering (GlobeNewswire) -31.64%
Aug-20-24 05:09PM	Eyenovia, Inc. Announces Proposed Public Offering (GlobeNewswire) -17.03%
Aug-15-24 12:00PM	Eyenovia (EYEN) Upgraded to Buy: Here's What You Should Know (Zacks)
Aug-13-24 07:00AM	Eyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference (GlobeNewswire) -9.08%
Aug-12-24 05:30PM	Eyenovia, Inc. (EYEN) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-08-24 07:00AM	Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th (GlobeNewswire) -6.16%
Aug-07-24 05:11PM	Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S. (GlobeNewswire)
08:00AM	Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States (PR Newswire)
Jul-30-24 08:00AM	Eyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease (GlobeNewswire)
Jul-23-24 07:00AM	Eyenovia and Senju Pharmaceutical Co., Ltd. Sign Collaboration Agreement for Potential New Treatment for Chronic Dry Eye Disease (GlobeNewswire) +14.17%
Jul-01-24 06:50AM	NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities (Business Wire) +14.27%
Jun-28-24 08:00AM	Eyenovia Announces Pricing of $5M Registered Direct Offering (GlobeNewswire) -14.16%
May-23-24 06:00AM	Peek Behind the Curtain: 7 Penny Stocks With Heavy Insider Buying (InvestorPlace) -7.49%
May-20-24 12:00PM	All You Need to Know About Eyenovia (EYEN) Rating Upgrade to Buy (Zacks)
May-16-24 03:07AM	Eyenovia Inc (EYEN) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ... (GuruFocus.com) -22.56%
May-15-24 08:55PM	EYEN Stock Earnings: Eyenovia Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) +28.28%
04:01PM	Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III Program and its Two FDA Approved Commercial Products, Mydcombi and Clobetasol (GlobeNewswire)
May-14-24 07:00AM	Eyenovia to Report First Quarter 2024 Results on Wednesday, May 15th (GlobeNewswire)
May-10-24 06:31AM	Formosa and Tabuk sign deal for FDA-approved ophthalmic suspension (Pharmaceutical Technology)
Apr-25-24 07:00AM	Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi and Clobetasol Propionate Ophthalmic Suspension (GlobeNewswire) +21.90%

Hyperion DeFi, Inc. is a long-term strategic treasury of Hyperliquid's native token HYPE. It provides investors with streamlined access to the Hyperliquid ecosystem and is also developing its proprietary Optejet user-filled device, designed for use with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. The firm operates through the Ophthalmic Technology and Digital Assets segments. The Ophthalmic Technology segment focuses on developing eye-care devices and delivery systems for ophthalmic liquids. The Digital Assets segment focuses on managing a strategic treasury of blockchain-based assets and exposure to the Hyperliquid ecosystem. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in Laguna Hills, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Knox David R.	Chief Financial Officer	Dec 31 '25	Buy	3.59	27,950	100,340	327,950	Jan 05 08:00 AM
Strahlman Ellen R	Director	Dec 29 '25	Buy	3.60	12,112	43,603	91,161	Dec 30 04:01 PM
Strahlman Ellen R	Director	Dec 29 '25	Buy	3.61	11,856	42,800	34,869	Dec 30 04:01 PM
Strahlman Ellen R	Director	Dec 26 '25	Buy	3.86	3,601	13,911	79,049	Dec 30 04:01 PM
Strahlman Ellen R	Director	Dec 26 '25	Buy	3.86	3,311	12,777	23,013	Dec 30 04:01 PM
Strahlman Ellen R	Director	Dec 18 '25	Buy	3.14	19,702	61,835	95,150	Dec 22 08:15 AM
Strahlman Ellen R	Director	Dec 18 '25	Buy	3.14	18,742	58,829	75,448	Dec 22 08:15 AM
Walters Happy David	Director	Dec 17 '25	Buy	3.02	61,930	187,152	111,930	Dec 19 07:21 PM
GELTZEILER MICHAEL S	Director	Dec 17 '25	Buy	3.01	30,000	90,210	88,015	Dec 19 11:00 AM
MATHER CHARLES E IV	Director	Jul 22 '25	Proposed Sale	12.86	1,362	17,515		Jul 22 11:20 AM

HYPD

Hyperion DeFi Inc

Upgrade your Finviz experience